H-Index
34
Scimago Lab
powered by Scopus
JCR
Clarivate
Analytics
call: +1.631.629.4327
Mon-Fri 10 am - 2 pm EST

Logo



eISSN: 2329-0358

Get your full text copy in PDF

Improvement of Graft Function following Roux-en-Y Gastric Bypass Surgery in a Morbidly Obese Kidney Recipient: A Case Report and Literature Review

Paweł Ziemiański, Wojciech Lisik, Rafał J. Marszałek, Tomasz Cieciura, Justyna Domienik-Karłowicz, Janusz Trzebicki, Tomasz Gryczewski, Zbigniew Wierzbicki, Maciej Kosieradzki, Magdalena Durlik, Piotr Pruszczyk, Andrzej Chmura

(Department of General Surgery and Transplantology, Transplantation Institute, Medical University of Warsaw, Warsaw, Poland)

Ann Transplant 2014; 19:639-642

DOI: 10.12659/AOT.892954


Background: Transplantation is the best and approved method of renal replacement therapy. Graft function depends not only on proper regulation of immune processes but also on the optimal control of chronic diseases. The obesity epidemic involves the healthy population and organ recipients equally. Obesity and metabolic syndrome lead to a number of disorders exerting adverse effects on the transplanted organ.
Case Report: We report a case of a kidney recipient, 12 years after transplantation, with chronic graft failure (serum creatinine level 2.1 mg/dl, GFR 31 ml/min/1.73 m2), morbid obesity (weight 139.8 kg, BMI 46.2 kg/m2, excess body mass 73.1 kg), hypertension, poorly controlled type 1 diabetes (HbA1c 8.8%), and ischemic heart disease. The cause of chronic kidney disease was diabetic nephropathy.
The patient was the first Polish kidney recipient referred for bariatric gastric bypass surgery (GB).
Directly after surgery, transient creatinine elevation (4.7 mg/dl) was noted. There was no reduction in diuresis. Desired weight loss was achieved within 12 months after surgery (body mass 81.9, BMI 27.1 kg/m2, percentage loss of excess weight 86.9%) with improved graft function (serum creatinine level 1.3 mg/dl, GFR 45.1 ml/min/1.73 m2) and reduction of daily insulin requirement from 74 to 40 units. The severity of hypertension and ischemic heart disease diminished as well.
Conclusions: Metabolic surgery is the best treatment of obesity and may contribute to post-transplantation care if weight gain is observed, as a result of the interaction of many factors leading to deterioration of renal graft function.

This paper has been published under Creative Common Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0) allowing to download articles and share them with others as long as they credit the authors and the publisher, but without permission to change them in any way or use them commercially.
I agree